Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2004-09-09
2008-10-21
Bernhardt, Emily (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S218000, C540S575000, C544S363000
Reexamination Certificate
active
07439244
ABSTRACT:
Disclosed are quinoline compounds of formula (I) having pharmacological activity, processes for their preparation, compositions containing them, and methods for the treatment of CNS and other disorders.
REFERENCES:
patent: 6251893 (2001-06-01), Slassi et al.
patent: WO 00/42026 (2000-07-01), None
patent: WO 00/63203 (2000-10-01), None
patent: WO 02/100822 (2002-12-01), None
patent: WO 03/035061 (2003-05-01), None
patent: WO 03/037871 (2003-05-01), None
patent: WO 03/037872 (2003-05-01), None
patent: WO 03/042208 (2003-05-01), None
patent: WO 03/080580 (2003-10-01), None
Robichaud et al. in Annual Reports in Medicinal Chemistry, vol. 36, p. 11-20 (2000).
Rogers et al. Psychopharmacology, vol. 158, p. 114-119 (2001).
Bromidge et al. Bioorganic & Medicinal Chemistry Letters, vol. 11, p. 55-58 (2001).
Ahmed et al. Bioorganic & Medicinal Chemistry Letters vol. 15, p. 4867-4871 (2005).
U.S. Appl. No. 10/509,078 filed Sep. 27, 2004, Ahmend et al.
Heal et al. Pharmacology & Therapeutics, vol. 117, p. 207-231 (2008).
Wooley et al.Neuropharmacology, vol. 41: 210-219 (2001).
Mitchell et al.,Pharmacol.&Therapeutics, 108: 320-333 (2005).
Chuang et al.,Alzheimer's&Dementia, The Journal of the Alzheimer's Association, 2(3/Supp. 1): S631-S632 (2006).
London Stock Exchange Announcement—GlaxoSmithKline (GSK) plc, Issued on Thursday, Dec. 13, 2007, New York, New York.
A Dose Ranging Study to Investigate the Efficacy and Safety of SB-742457 in Alzheimer'Disease. NCT ID No. NCT00224497 (Verified 2007).
SB-742457 and Donepezil in Alzheimer's Disease. NCT ID No. NCT00348192 (2006).
Garcia-Alloza et al.Neuropsychopharmacology, 29: 410-416 (2004).
Johnson Christopher Norbert
Witty David R
Bernhardt Emily
Glaxo Group Limited
Kinzig Charles M.
McCarthy Mary E.
Sieburth Kathryn L.
LandOfFree
Quinoline compounds and pharmeceutical compositions... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Quinoline compounds and pharmeceutical compositions..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Quinoline compounds and pharmeceutical compositions... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4009678